These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29266276)

  • 21. In vitro properties of apheresis platelet during extended storage in plasma treated with anandamide.
    Zhuang Y; Ren G; Li H; Tian K; Zhang Y; Qiao W; Nie X; Liu Y; Song Y; Zhu C
    Transfus Apher Sci; 2014 Aug; 51(1):58-64. PubMed ID: 25129827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelets stored in whole blood at 4°C: in vivo posttransfusion platelet recoveries and survivals and in vitro hemostatic function.
    Slichter SJ; Fitzpatrick L; Osborne B; Christoffel T; Gettinger I; Pellham E; Bailey SL; Jones MK; Herzig MC; Cap AP
    Transfusion; 2019 Jun; 59(6):2084-2092. PubMed ID: 30977914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the automated collection and extended storage of apheresis platelets in additive solution.
    Johnson L; Winter KM; Hartkopf-Theis T; Reid S; Kwok M; Marks DC
    Transfusion; 2012 Mar; 52(3):503-9. PubMed ID: 21880041
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of bicarbonate in platelet additive solution for apheresis platelet concentrates stored with low residual plasma.
    Radwanski K; Min K
    Transfusion; 2013 Mar; 53(3):591-9. PubMed ID: 22725609
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Apoptotic markers are increased in platelets stored at 37 degrees C.
    Bertino AM; Qi XQ; Li J; Xia Y; Kuter DJ
    Transfusion; 2003 Jul; 43(7):857-66. PubMed ID: 12823744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Paired in vitro and in vivo comparison of apheresis platelet concentrates stored in platelet additive solution for 1 versus 7 days.
    Shanwell A; Diedrich B; Falker C; Jansson B; Sandgren P; Sundkvist L; Svensson L; Vesterinen M; Gulliksson H
    Transfusion; 2006 Jun; 46(6):973-9. PubMed ID: 16734814
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Storage of buffy coat-derived platelets in additive solutions: in vitro effects of storage at 4 degrees C.
    Sandgren P; Shanwell A; Gulliksson H
    Transfusion; 2006 May; 46(5):828-34. PubMed ID: 16686851
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets.
    Dumont LJ; Gulliksson H; van der Meer PF; Murphy S; Nixon JG; de Wildt-Eggen J; Vandenbroeke T; Aubuchon JP
    Transfusion; 2007 Sep; 47(9):1666-73. PubMed ID: 17725732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of pH on stored human platelets.
    Dekkers DW; De Cuyper IM; van der Meer PF; Verhoeven AJ; de Korte D
    Transfusion; 2007 Oct; 47(10):1889-95. PubMed ID: 17880616
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Storage of buffy-coat-derived platelets in additive solutions: in vitro effects on platelets stored in reformulated PAS supplied by a 20% plasma carry-over.
    Sandgren P; Mayaudon V; Payrat JM; Sjödin A; Gulliksson H
    Vox Sang; 2010 Apr; 98(3 Pt 2):415-22. PubMed ID: 19788514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An in vitro pilot study of apheresis platelets collected on Trima Accel system and stored in T-PAS+ solution at refrigeration temperature (1-6°C).
    Reddoch-Cardenas KM; Sharma U; Salgado CL; Montgomery RK; Cantu C; Cingoz N; Bryant R; Darlington DN; Pidcoke HF; Kamucheka RM; Cap AP
    Transfusion; 2019 May; 59(5):1789-1798. PubMed ID: 30725491
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between in vitro aggregation and thromboxane A2 production in fresh, liquid-preserved, and cryopreserved human platelets: effect of agonists, pH, and plasma and saline resuspension.
    Valeri CR; Macgregor H; Ragno G
    Transfusion; 2005 Apr; 45(4):596-603. PubMed ID: 15819682
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of different hold time before addition of platelet additive solution on the in vitro quality of apheresis platelets.
    Ringwald J; Haager B; Krex D; Zimmermann R; Strasser E; Antoon M; De Schrijver E; Eckstein R
    Transfusion; 2006 Jun; 46(6):942-8. PubMed ID: 16734810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cold storage of platelets in platelet additive solution: an in vitro comparison of two Food and Drug Administration-approved collection and storage systems.
    Reddoch-Cardenas KM; Montgomery RK; Lafleur CB; Peltier GC; Bynum JA; Cap AP
    Transfusion; 2018 Jul; 58(7):1682-1688. PubMed ID: 29603238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vivo viability of extended 4°C-stored autologous apheresis platelets.
    Stolla M; Fitzpatrick L; Gettinger I; Bailey SL; Pellham E; Christoffel T; Slichter SJ
    Transfusion; 2018 Oct; 58(10):2407-2413. PubMed ID: 30203458
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A hollow-fibre column system to effectively prepare washed platelets.
    Tanaka S; Hayashi T; Sugaya S; Osabe M; Ueno Y; Tani Y; Hirayama F
    Vox Sang; 2015 Oct; 109(3):239-47. PubMed ID: 25953437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Temperature cycling improves in vivo recovery of cold-stored human platelets in a mouse model of transfusion.
    Xu F; Gelderman MP; Farrell J; Vostal JG
    Transfusion; 2013 Jun; 53(6):1178-86. PubMed ID: 22998069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro properties of platelets stored in three different additive solutions.
    Tynngård N; Trinks M; Berlin G
    Transfusion; 2012 May; 52(5):1003-9. PubMed ID: 22043825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thrombin receptor levels in platelet concentrates during storage and their impact on platelet functionality.
    Schlagenhauf A; Kozma N; Leschnik B; Wagner T; Muntean W
    Transfusion; 2012 Jun; 52(6):1253-9. PubMed ID: 22233332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of cold storage on platelets treated with Intercept pathogen inactivation.
    Six KR; Devloo R; Compernolle V; Feys HB
    Transfusion; 2019 Aug; 59(8):2662-2671. PubMed ID: 31187889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.